• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVIS & GECK CARIBE LTD BIOSYN; SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC AC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVIS & GECK CARIBE LTD BIOSYN; SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC AC Back to Search Results
Model Number SM-5638
Medical Device Problem Code Unraveled Material (1664)
Health Effect - Clinical Codes Wound Dehiscence (1154); Pain (1994)
Date of Event 05/28/2024
Type of Reportable Event Serious Injury
Event or Problem Description
According to the reporter, 44 days following an open total knee replacement procedure wherein 4 sutures were used for closure, the p patient was readmitted with knee pain and wound dehiscence; the suture line did not hold.The patient underwent another surgery to resolve the issue.
 
Additional Manufacturer Narrative
D10 concomitant products: 88863097-71, 88863097-71 ticron* 1 blu 75cm gs25x36 (lot# unknown) cl-830, cl-830 polysorb 2-0 und 75cm gs22 x36 (lot# unknown) cl-964, cl-964 polysorb* 0 und 90cm gs24 x36 (lot# unknown) 88862818-89, 88862818-89 ticron* 5 blu 4x75cm kv40x12 (lot# unknown) sm-5638, sm-5638 biosyn* 3-0 und 75cm p12 x12 (lot# unknown) sm-5638, sm-5638 biosyn* 3-0 und 75cm p12 x12 (lot# unknown) sm-5638, sm-5638 biosyn* 3-0 und 75cm p12 x12 (lot# unknown) medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Evaluation summary: medtronic conducted an investigation based upon all information received.Four monofilament suture fragments opened by the account without the packaging were available for evaluation.Visual inspection noted that two fragments were monofilament and dyed violet.Unfortunately, these fragments could not be matched with any of the product descriptions reported.It was reported that the suture line did not hold.The reported issue was confirmed.The most likely cause could not be established from the information available.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOSYN
Common Device Name
SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC AC
Manufacturer (Section D)
DAVIS & GECK CARIBE LTD
zona franca de san isidro
santo domingo 0101
DR  0101
Manufacturer (Section G)
DAVIS & GECK CARIBE LTD
zona franca de san isidro
santo domingo 0101
DR   0101
Manufacturer Contact
justin ellis
8200 coral sea st ne
mounds view, MN 55112
7635265677
MDR Report Key19606485
Report Number9612501-2024-01544
Device Sequence Number18194031
Product Code GAM
UDI-Device Identifier10884521033085
UDI-Public10884521033085
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K000037
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberSM-5638
Device Catalogue NumberSM-5638
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/31/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/29/2024
Supplement Date Received by Manufacturer08/07/2024
Initial Report FDA Received Date06/25/2024
Supplement Report FDA Received Date08/22/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age76 YR
Patient SexFemale
-
-